MedMira (MedMira) Gross Margin % : 45.95% (As of Jan. 2024)

View and export this data going back to . Start your Free Trial

What is MedMira Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. MedMira's Gross Profit for the three months ended in Jan. 2024 was $0.05 Mil. MedMira's Revenue for the three months ended in Jan. 2024 was $0.11 Mil. Therefore, MedMira's Gross Margin % for the quarter that ended in Jan. 2024 was 45.95%.

Warning Sign:

MedMira Inc gross margin has been in long-term decline. The average rate of decline per year is -8.5%.

The historical rank and industry rank for MedMira's Gross Margin % or its related term are showing as below:

MMIRF' s Gross Margin % Range Over the Past 10 Years
Min: 29.12 Med: 63.12 Max: 80.32
Current: 61.52

During the past 13 years, the highest Gross Margin % of MedMira was 80.32%. The lowest was 29.12%. And the median was 63.12%.

MMIRF's Gross Margin % is ranked better than
51.74% of 746 companies
in the Biotechnology industry
Industry Median: 59.74 vs MMIRF: 61.52

MedMira had a gross margin of 45.95% for the quarter that ended in Jan. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for MedMira was -8.50% per year.

MedMira Gross Margin % Historical Data

The historical data trend for MedMira's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira Gross Margin % Chart

MedMira Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Gross Margin %

Get a 7-Day Free Trial

80.35

62.26

80.30

31.93

69.21

MedMira Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Gross Margin %	Get a 7-Day Free Trial															52.76	56.96	150.00	60.47	45.95

Competitive Comparison of MedMira's Gross Margin %

For the Biotechnology subindustry, MedMira's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedMira's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MedMira's Gross Margin % distribution charts can be found below:

* The bar in red indicates where MedMira's Gross Margin % falls into.

MedMira Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

MedMira's Gross Margin for the fiscal year that ended in Jul. 2023 is calculated as

Gross Margin % (A: Jul. 2023 )	=	Gross Profit (A: Jul. 2023 )	/	Revenue (A: Jul. 2023 )
	=	0.2	/	0.328
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.328 - 0.101)	/	0.328
	=	69.21 %

MedMira's Gross Margin for the quarter that ended in Jan. 2024 is calculated as

Gross Margin % (Q: Jan. 2024 )	=	Gross Profit (Q: Jan. 2024 )	/	Revenue (Q: Jan. 2024 )
	=	0.1	/	0.111
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.111 - 0.06)	/	0.111
	=	45.95 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

MedMira (OTCPK:MMIRF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

MedMira had a gross margin of 45.95% for the quarter that ended in Jan. 2024 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

MedMira Gross Margin % Related Terms

Thank you for viewing the detailed overview of MedMira's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMira (MedMira) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (OTCPK:MMIRF) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

47M:Germany MIR:Canada

Address

155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3

Website

https://www.medmira.com

MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.